Insiders | Shares | % | Avg Price | Total $ | |
---|---|---|---|---|---|
Buys | 0 | ||||
Sells | 1 | -650K | 100% | $35.36 | -$23M |
Net | -1 | -650K | -100% | -$23M |
Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Decheng Capital Global Life Sciences Fund IV, L.P. | 10%+ Owner | $175M | Jan 29, 2024 | ||
Hong Fang Song | Director | $173M | -$23M | -11.7% | Aug 29, 2024 |
Arthur Kuan | Chief Executive Officer, Director | $1.28M | Jan 24, 2024 | ||
Corleen Roche | CFO & Secretary | $70.7K | Jan 29, 2024 | ||
Vijay Kasturi | Chief Medical Officer | $46.5K | Jan 29, 2024 | ||
James Mulay | Director | Jan 24, 2024 | |||
Joshua F. Patterson | General Counsel and Chief Compliance Officer | May 15, 2024 | |||
Leonard E. Post | Director | Jan 24, 2024 | |||
Ambaw Bellete | President and COO | Jan 24, 2024 | |||
Brian Liu | Director | Jan 24, 2024 | |||
Victor Tong | Director | Jan 24, 2024 | |||
Susan Graf | Director | Jan 24, 2024 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|